Lipocine Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 221.87 K | $634.54 K | -1.34% | 4.15% |
| BLACKROCK, INC. | 11/12/2025 | 89.27 K | $254.43 K | 0.00% | 1.67% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 61.08 K | $174.70 K | 0.00% | 1.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 46.76 K | $133.74 K | 1.61% | 0.87% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 36.10 K | $102.88 K | 3.74% | 0.67% |
| STATE STREET CORP | 11/14/2025 | 18.63 K | $53.27 K | 0.00% | 0.35% |
| CITADEL ADVISORS LLC | 11/14/2025 | 14.25 K | $40.75 K | 100.00% | 0.27% |
| NORTHERN TRUST CORP | 11/14/2025 | 13.16 K | $37.51 K | 0.00% | 0.25% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 12.14 K | $34.72 K | -49.12% | 0.23% |
| BARCLAYS PLC | 11/12/2025 | 9.41 K | $26.82 K | 0.00% | 0.18% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 2.27 K | $6.46 K | -0.83% | 0.04% |
| UBS GROUP AG | 11/13/2025 | 1.77 K | $5.03 K | 271.79% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.17 K | $3.33 K | 73.85% | 0.02% |
| MORGAN STANLEY | 11/14/2025 | 575 | $1.64 K | 0.00% | 0.01% |
| CALDWELL SUTTER CAPITAL, INC. | 10/29/2025 | 471 | $1.34 K | 0.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 162 | $463 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 67 | $191 | 0.00% | 0.00% |
| FMR LLC | 11/13/2025 | 59 | $169 | 100.00% | 0.00% |
| TIDEMARK, LLC | 11/03/2025 | 59 | $168 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 49 | $139 | -98.11% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 3 | $9 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lipocine Inc. institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Lipocine Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 221,867
BlackRock, Inc.: 89,272
GEODE CAPITAL MANAGEMENT, LLC: 61,076
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 46,761
RENAISSANCE TECHNOLOGIES LLC: 36,097
STATE STREET CORP: 18,626
9.89% of Lipocine Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.90 M shares in the last 24 months. This purchase volume represents approximately $9.71 M in transactions.